NKTR

Bearish

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nektar Therapeutics (NKTR) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Nektar Therapeutics (NASDAQ:NKTR) and its offi...

ACCESS Newswire 2 weeks ago 0

Neutral

Nektar Therapeutics 8-K SEC Filing: Company Details, Common Stock, and NASDAQ Listing (June 2026)

Nektar Therapeutics reported the results of its Annual Meeting of Stockholders held on June 4, 2026, including the re-election of directors and the ra...

Minichart 3 weeks ago 0

Neutral

What Makes Nektar Therapeutics (NKTR) a Promising Mid-Cap Healthcare Stock

Nektar Therapeutics (NKTR) is highlighted as a promising mid-cap healthcare stock, with analysts offering differing perspectives on its future. Wedbus...

Insider Monkey 4 weeks ago 0